Market Place
Sourcing Support
AmbioPharm Breaks Ground on $28M Expansion in Manufacturing Site
21 Nov 2024 //
PHARMAWEB
AmbioPharm Appoints Industry Veteran Brian Gregg as CEO
02 Oct 2023 //
BUSINESSWIRE
CombiGene selects AmbioPharm as peptide CDMO partner for their COZY01 pain project
15 Sep 2023 //
PRESS RELEASE
AmbioPharm, a Global Peptide CDMO
25 Jul 2023 //
BUSINESSWIRE
AmbioPharm Expands South Carolina Headquarters
18 May 2023 //
CONTRACT PHARMA
AmbioPharm Provides an Update on South Carolina Headquarters Expansion
17 May 2023 //
BUSINESSWIRE
AmbioPharm Provides an Update on Shanghai Campus Expansion and Resumption
25 Apr 2023 //
BUSINESSWIRE
AmbioPharm To Utilize YMC Twin-Column Chromatography in Peptide Production
28 Mar 2023 //
BUSINESSWIRE
AmbioPharm to Host Sustainable Peptide Manufacturing Workshop at Biologics 2023
22 Mar 2023 //
BUSINESSWIRE
Latest Publication in eLife on Non-Opioid Peptide-Based Pain Therapeutics
03 Jan 2023 //
PRESS RELEASE
Ariceum and AmbioPharm Enter Strategic Manufacturing & Supply Partnership
27 Oct 2022 //
PRESS RELEASE
Then and Now: Celebrating 15 Years in North Augusta, SC USA
27 Sep 2022 //
PRESS RELEASE
OKYO Pharma Plans Q4 2022 IND Filing OK-101 to treat Dry Eye Disease AmbioPharm
30 Aug 2022 //
GLOBENEWSWIRE
Amytrx Tx Partners With AmbioPharm to Expand Anti-Inflammatory Peptides
27 Jul 2022 //
BUSINESSWIRE
AmbioPharm Supports ONL Therapeutics with Peptide Manufacturing for PII Study
12 Jul 2022 //
BUSINESSWIRE
Peptide Synthesis Strategies
13 Jun 2022 //
PRESS RELEASE
Spotlight on a New Peptide Approval, Tirzepatide
25 May 2022 //
PRESS RELEASE
Adalvo announces successful launch of Icatibant in close collaboration Ambio
27 Jan 2022 //
PRESS RELEASE
Adalvo announces successful DCP closure for Icatibant in close collaboration with strategic partner AmbioPharm
28 Sep 2021 //
PRESS RELEASE
CEM Corporation and AmbioPharm Partner in United States to Produce BPF Peptides
14 Sep 2021 //
BUSINESSWIRE
AmbioPharm Inc. Working with University of California Davis to Develop Non-Opioid Peptide-Based Pain Therapeutics
20 Jul 2021 //
PRESS RELEASE
AmbioPharm Inc. Announces New Shanghai Campus Opening and European Executive Team Members
07 Jan 2021 //
PRESS RELEASE
Upsher-Smith and AmbioPharm Announce Partnership Agreement to Develop
07 Aug 2020 //
PRESS RELEASE
Adalvo & AmbioPharm partner on development & licensing for key peptide products
29 Jul 2020 //
PRESS RELEASE
AmbioPharm Inc. Expands Peptide Production Helping Fight Against Covid-19
30 Jun 2020 //
BUSINESSWIRE
Critical deadline for generic insulin production is now just weeks away
28 Feb 2020 //
KITV
AmbioPharm announces new Senior Vice President of Quality at its North Augusta
19 Aug 2019 //
PRESS RELEASE
AmbioPharm announces new Senior Director of Peptide Manufacturing at its North Augusta, SC facility
28 Nov 2018 //
PRESS RELEASE
AmbioPharm announces new Chief Scientific Officer
04 Oct 2018 //
PRESS RELEASE
The Carlyle Group Acquires Significant Minority Stake in Ambio
10 Sep 2018 //
PRESS RELEASE
Gattex (Teduglutide): Shire-NPS Pharma v. AmbioPharm & Par Pharmaceutical
10 Apr 2017 //
PATENT LITIGATION
